AMETEK, Inc. Receives Moderate Buy Consensus From Analysts

According to analyst reports collated by MarketBeat.com, AMETEK, Inc. (NYSE:AME) has been given an average recommendation of 'Moderate Buy' by the nine brokerages currently covering the firm. Within this analyst group, three have issued hold ratings, while six suggest a buy strategy for the company's stock. The average twelve-month price target set by these brokerages stands at $172.22.

Brokerage Perspectives on AMETEK

Analyst sentiments on AMETEK have shown variation. Notably, StockNews.com shifted their rating from 'buy' to 'hold.' On the other hand, BNP Paribas initiated coverage with a 'neutral' stance and a price target of $159.00. Royal Bank of Canada uplifted their target from $183.00 to $186.00, maintaining an 'outperform' rating, whereas TD Cowen changed their rating to 'market perform' and lowered their price target from $165.00 to $160.00.

Insider Sales and Shareholder Structure

Interesting movements have also occurred within the company's insiders, with Director Steven W. Kohlhagen selling 810 shares at an average price of $155.09, totaling $125,622.90. After this sale, Dr. Kohlhagen directly holds 29,454 shares, estimated at over $4.56 million. This and other sales are disclosed in documents filed with the SEC.

Institutional investors have been actively adjusting their positions in AMETEK, signalling confidence or reservations aligned with market trends. For instance, Covestor Ltd significantly increased its AMETEK holdings by 84.3%, and multiple new stakes were initiated by investors like Resurgent Financial Advisors LLC and Mascoma Wealth Management LLC. Overall, institutions possess 85.70% of AMETEK's shares.

Recent Stock Performance

On the performance front, AMETEK's stock began trading at $164.20 recently, with key financial ratios indicating stability. The company has demonstrated resilience with its debt-to-equity ratio at 0.22 and liquidity ratios above industry standards. The stock's 50-day and 200-day moving averages were $151.71 and $154.14, respectively, highlighting a favorable trend. Moreover, AMETEK recorded a 52-week trading range between $131.52 and $165.04, showcasing its volatilities and opportunities within the market.

For the quarterly earnings reported on October 31st, AMETEK surpassed expectations with an EPS of $1.64 against the forecasted $1.58. Their quarterly revenue also mirrored organic growth, climbing by 4.6% compared to the same quarter in the previous year. Analysts predict that AMETEK's annual EPS could reach $6.33.

Dividend Insights

AMETEK has also declared a quarterly dividend, with the most recent payment being made to shareholders on record as of December 8th. This distribution reflected an annualized dividend of $1.00 and a yield of 0.61%, translating to a modest dividend payout ratio of 18.12%.

About AMETEK, Inc.

As an international manufacturer with a diverse product portfolio, AMETEK, Inc. operates in two primary segments: Electronic Instruments (EIG) and Electromechanical (EMG). The EIG segment delivers advanced instrumentation to various markets, whereas the EMG segment provides essential electromechanical devices for a range of applications. Both segments collectively support AMETEK's strategic market presence in North America, Europe, Asia, and South America.

AMETEK, ModerateBuy, Analysts